MYDA Advisors »

Tg Therapeutics shares owned by MYDA Advisors

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by MYDA Advisors from 13F filings

Historical chart of MYDA Advisors investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by MYDA Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by MYDA Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $936k 40k 23.39
2024-06-30 $356k 20k 17.79

More positions owned by MYDA Advisors

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Netflix (NFLX)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Cogent Communications Hldgs Com New (CCOI)
Core Scientific (CORZ)
Amazon (AMZN)
Tesla Motors Call Option (TSLA)
Golar Lng SHS (GLNG)
Vertiv Holdings Com Cl A (VRT)
Microsoft Corporation (MSFT)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Prologis (PLD)
MGM Resorts International. (MGM)

View all positions for MYDA Advisors

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
BlackRock
State Street Corporation
Soleus Capital Management
Pictet Asset Management Holding SA
Geode Capital Management
Deep Track Capital
Woodline Partners
Susquehanna International
Opaleye Management
Goldman Sachs Group
Bank of America Corporation
Nuveen Asset Management
Morgan Stanley

View all funds holding Tg Therapeutics